Custom Search

Register
Sign In
Sign In Using Facebook

US AIDS Clinics Ban Merck Reps Over Drug Costs

by Rajshri on  January 26, 2010 at 7:41 PM AIDS/HIV News
  •   Print
  •   Share
  •   Comments
  •  Text 
Merck Pharmaceuticals has been accused of of price-gouging its AIDS treatment Isentress by the largest US HIV/AIDS health care provider, which has banned the drug giant's sales reps from its clinics in protest.
 US AIDS Clinics Ban Merck Reps Over Drug Costs


"We've banned representatives from Merck Pharmaceuticals from calling on our physicians in our clinics, which is a common marketing strategy. We are instituting this ban largely because of the egregious pricing policies for their key AIDS drug, Isentress," Ged Kinslea, communications director for the AIDS Healthcare Foundation (AHF), told AFP.

"The drug is a good drug, it has fewer side effects... but it is the single most expensive first-line anti-retroviral treatment for AIDS available in the United States and the developing world," said Kinslea.

An annual course of Isentress costs in the region of 12,870 dollars in the United States, according to AHF.

In Africa, the continent the worst-hit by the global AIDS pandemic, Isentress costs "about 1,100 US dollars per patient, per year and that's about 20 times more than other AIDS drugs in Africa," said Kinslea.

Isentress was brought to market in the United States in 2007 as a so-called salvage therapy drug -- a treatment for patients for whom other AIDS therapies have not worked or who only sought treatment in the late stages of illness, AHF said.

Last year, the US Food and Drug Administration approved Isentress as a first-line treatment for AIDS, "but the pricing remains at the expensive, salvage-therapy price," said Kinslea.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

01/26/2010

I think it is about time that someone ban these practices. All of these life-saving drugs are overpriced, definitely in America. We want health care reform, but they have so much money to fight any kind of real reform because of their unfair practices. If we could stop these companies from doing these ridiculous things it would help everyone. A years worth of Atripla in America costs around $14,400, so this is not the first medication which has outrageous costs.




X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Infectious News - Focus on HIV
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
AIDS
Complete Medindia Resources
News Categories:  
Child Health Center

AIDS/HIV Related News

» AIDS Drug Venture in South Africa Worth $208 Million » Men Need More Attention in HIV Prevention
» Study Sheds Light on Psychiatric Symptoms and Functional Outcomes in HIV-Infected Youth » 20% Gay, Bisexual Men Unaware About Their HIV Positive Status
» Strained Global AIDS Fund Moves Focus Ten Years On » Scarce Access to Anti-Retrovirals for DR Congo HIV Patients
» Research Says Pet Love Helps Women Cope With HIV/AIDS » Saliva HIV Test as Accurate as Blood Test for HIV: Study
Read More >>